Best of the IN VIVO Blog, August 2009
A selection of our favorite blog posts from August 2009 for stories not covered elsewhere in this month's IN VIVO. (See the original postings for free at http://invivoblog.blogspot.com/).
You may also be interested in...
Article and editorial discuss potential for testing for non-responders to Plavix to guide treatment. Issue will be central to Effient launch - but will cardiologists embrace genetic screening?
Not satisfied with its R&D experiments to date, GSK has taken its most radical step yet toward re-creating biotech within its walls: even smaller units complete with investment boards occupied by external VCs and CEOs and milestone-based funding and external VCs.
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.